logo

For the Inventor, By the Inventor

Mountain View, CA, United States of America

Tosk, Incorporated

Calculating rank
USPTO Granted Patents = 22



Forward Citations = 52

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal William A Garland (18 out of 38 patents)

silverMedal Brian D Frenzel (16 out of 16 patents)

bronzeMedal Philip Liaw (10 out of 10 patents)

4.  Solomon B Ungashe (5 out of 5 patents)

5.  Stephen D Yanofsky (5 out of 5 patents)

6.  Travis Karg (5 out of 5 patents)

7.  Annie L Lennek (4 out of 4 patents)

8.  Patrick Fogarty (3 out of 3 patents)

9.  Heshan Peiris (2 out of 2 patents)

10.  Steve Yanofsky (1 out of 1 patent)

11.  Joseph Konopelski (0 patent)

12.  Todd Wipke (0 patent)


22 patents:

1. 12667571 - Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions (2026-06-30),
2. 12528796 - Modulators of RAS GTPase (2026-01-20),
3. 12508265 - Methods and compositions for reducing radiation induced toxicity (2025-12-30),
4. 12486255 - Modulators of RAS GTPase (2025-12-02),
5. 12419893 - Methods and compositions for maximizing the prevention and/or reduction of various maladies and drug side-effects using uridine (2025-09-23),
6. 12194043 - Uridine phosphorylase inhibitors to treat or prevent pulmonary disease (2025-01-14),
7. 12180220 - Heteroaryl modulators of RAS GTPase (2024-12-31),
8. 12109222 - Methods and compositions for treating mucositis (2024-10-08),
9. 11945803 - Modulators of RAS GTPase (2024-04-02),
10. 11446303 - Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions (2022-09-20),
11. 11390626 - Pyrazolopyrimidine modulators of RAS GTPase (2022-07-19),
12. RE48253 - Methotrexate adjuvants to reduce toxicity and methods for using the same (2020-10-12),
13. 10660318 - Non-mammalian RAS transgenic animal model (2020-05-26),
14. 9468613 - Doxorubicin adjuvants to reduce toxicity and methods for using the same (2016-10-18),
15. 9382287 - Methotrexate adjuvants to reduce toxicity and methods for using the same (2016-07-05),
Company Overview
Tosk, Incorporated is a technology company based in Mountain View, California, specializing in the development of innovative solutions in the field of biotechnology. The organization focuses on advancing drug discovery and development processes, utilizing proprietary platforms to enhance the efficiency and effectiveness of therapeutic interventions. Tosk's research efforts are aimed at addressing complex medical challenges, leveraging cutting-edge methodologies to contribute to the evolving landscape of healthcare and pharmaceuticals.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Tosk, Incorporated USPTO Patent Assignee Logo
22 Patents

#142 in Mountain View, CA

#3,592 in California

#15,057 in US

#28,822 in the World

Mountain View, CA (US)
Mountain View, CA, United States of America

Tosk, Incorporated

Forward Citations = 52

10 inventors:

goldMedal William A Garland (18 out of 38 patents)

silverMedal Brian D Frenzel (16 out of 16 patents)

bronzeMedal Philip Liaw (10 out of 10 patents)

4.  Solomon B Ungashe (5 out of 5 patents)

5.  Stephen D Yanofsky (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tosk, Incorporated. Retrieved from https://idiyas.com/company/tosk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…